Difference between revisions of "Part:BBa K5131000"
Line 5: | Line 5: | ||
Our project aimes to construct an in vivo SARS-CoV-2 nsp5 inhibitor screening platform, so we first needed to verify that the nsp5 we expressed in <html><i>E. coli</I></html> BL21 was functional. We utilises pGEX-6P-1 to express this part(<bbpart>BBa_K5131006</bbpart>). However, the molecular weight of the purified protein differs from the expected molecular weight of nsp5 (33.8 kDa). We determined the reason and investigated how the GST tag might affect nsp5 enzymatic activity based on structure prediction. | Our project aimes to construct an in vivo SARS-CoV-2 nsp5 inhibitor screening platform, so we first needed to verify that the nsp5 we expressed in <html><i>E. coli</I></html> BL21 was functional. We utilises pGEX-6P-1 to express this part(<bbpart>BBa_K5131006</bbpart>). However, the molecular weight of the purified protein differs from the expected molecular weight of nsp5 (33.8 kDa). We determined the reason and investigated how the GST tag might affect nsp5 enzymatic activity based on structure prediction. | ||
<h2> <b> About SARS-CoV-2 nsp5 </b> </h2> | <h2> <b> About SARS-CoV-2 nsp5 </b> </h2> | ||
− | Non-structural protein 5 (nsp5) is the most highly conserved non-structural protein across the Coronaviridae family, with a molecular weight of approximately 33 kDa[1]. In SARS-CoV-2, it's referred to as the main protease due to its pivotal role in the cleavage of polyproteins. Nsp5 has up to 11 conserved cleavage sites on the polyprotein and first undergoes autolytic cleavage to release itself, after which it cleaves at these sites to release other non-structural proteins. | + | Non-structural protein 5 (nsp5) is the most highly conserved non-structural protein across the Coronaviridae family, with a molecular weight of approximately 33 kDa<sup>[1]</sup>. In SARS-CoV-2, it's referred to as the main protease due to its pivotal role in the cleavage of polyproteins. Nsp5 has up to 11 conserved cleavage sites on the polyprotein and first undergoes autolytic cleavage to release itself, after which it cleaves at these sites to release other non-structural proteins. |
− | Nsp5 consists of three structural domains: two N-terminal domains with protease activity and a C-terminal domain composed of α-helices. The active form of SARS-CoV-2 nsp5 is a homodimer that recognizes substrates approximately 10 amino acid residues in length, but exhibits selectivity at only four specific positions[2]. In addition to cleaving viral proteins, nsp5 also suppresses the host innate immune response by degrading host protein factors[3]. In this project, our primary goal is to express functional nsp5 in E.coli BL21 in preparation for in vivo inhibitor screening. Additionally, since nsp5 has the ability to recognize and cleave specific sequences, we also aim to develop it as a tool enzyme for removing recombinant tags during protein purification. | + | Nsp5 consists of three structural domains: two N-terminal domains with protease activity and a C-terminal domain composed of α-helices. The active form of SARS-CoV-2 nsp5 is a homodimer that recognizes substrates approximately 10 amino acid residues in length, but exhibits selectivity at only four specific positions<sup>[2]</sup>. In addition to cleaving viral proteins, nsp5 also suppresses the host innate immune response by degrading host protein factors<sup>[3]</sup>. In this project, our primary goal is to express functional nsp5 in <i>E. coli</i> BL21 in preparation for in vivo inhibitor screening. Additionally, since nsp5 has the ability to recognize and cleave specific sequences, we also aim to develop it as a tool enzyme for removing recombinant tags during protein purification. |
<html> | <html> | ||
<div style="text-align:center;"> | <div style="text-align:center;"> | ||
Line 39: | Line 39: | ||
</html> | </html> | ||
<h2> <b> Express validation of nsp5 </b> </h2> | <h2> <b> Express validation of nsp5 </b> </h2> | ||
− | We expressed the protein in E. coli BL21 and purified it using Ni-NTA affinity chromatography. Protein expression was induced by adding IPTG to a final concentration of 0.2 mM. SDS-PAGE analysis showed that the purified and cleaved protein had high purity. However, the band appeared around 70 kDa(Figure 3), which differs from the expected molecular weight of nsp5 (33.8 kDa). Purification details can be seen in <html><a href="https://2024.igem.wiki/squirrel-shanghai/engineering">Engineering Success</a></html> | + | We expressed the protein in <i>E. coli</i> BL21 and purified it using Ni-NTA affinity chromatography. Protein expression was induced by adding IPTG to a final concentration of 0.2 mM. SDS-PAGE analysis showed that the purified and cleaved protein had high purity. However, the band appeared around 70 kDa(Figure 3), which differs from the expected molecular weight of nsp5 (33.8 kDa). Purification details can be seen in <html><a href="https://2024.igem.wiki/squirrel-shanghai/engineering">Engineering Success</a></html> |
<html> | <html> | ||
<div style="text-align:center;"> | <div style="text-align:center;"> |
Revision as of 13:26, 2 October 2024
SARA-Cov-2 nsp5
Our project aimes to construct an in vivo SARS-CoV-2 nsp5 inhibitor screening platform, so we first needed to verify that the nsp5 we expressed in E. coli BL21 was functional. We utilises pGEX-6P-1 to express this part(BBa_K5131006). However, the molecular weight of the purified protein differs from the expected molecular weight of nsp5 (33.8 kDa). We determined the reason and investigated how the GST tag might affect nsp5 enzymatic activity based on structure prediction.
About SARS-CoV-2 nsp5
Non-structural protein 5 (nsp5) is the most highly conserved non-structural protein across the Coronaviridae family, with a molecular weight of approximately 33 kDa[1]. In SARS-CoV-2, it's referred to as the main protease due to its pivotal role in the cleavage of polyproteins. Nsp5 has up to 11 conserved cleavage sites on the polyprotein and first undergoes autolytic cleavage to release itself, after which it cleaves at these sites to release other non-structural proteins. Nsp5 consists of three structural domains: two N-terminal domains with protease activity and a C-terminal domain composed of α-helices. The active form of SARS-CoV-2 nsp5 is a homodimer that recognizes substrates approximately 10 amino acid residues in length, but exhibits selectivity at only four specific positions[2]. In addition to cleaving viral proteins, nsp5 also suppresses the host innate immune response by degrading host protein factors[3]. In this project, our primary goal is to express functional nsp5 in E. coli BL21 in preparation for in vivo inhibitor screening. Additionally, since nsp5 has the ability to recognize and cleave specific sequences, we also aim to develop it as a tool enzyme for removing recombinant tags during protein purification.
Sequence design of pGEX-GST-nsp5-His
To ensure soluble expression of the protein, we selected the pGEX-6P-1 vector, which includes a GST tag and an HRV 3C protease cleavage site. For purification, we fused a 6*His tag to the C-terminus of the nsp5 sequence while retaining the HRV 3C protease cleavage site for subsequent removal of the tag(Figure 1).
Construction of pGEX-GST-nsp5-His
We first successfully amplified the vector backbone and the nsp5-6His tag separately using PCR (Figure 2B). Subsequently, we constructed the pGEX-GST-nsp5-His through homologous recombination. The sequencing results confirmed the correct construction of our vector(Figure 2C).
Express validation of nsp5
We expressed the protein in E. coli BL21 and purified it using Ni-NTA affinity chromatography. Protein expression was induced by adding IPTG to a final concentration of 0.2 mM. SDS-PAGE analysis showed that the purified and cleaved protein had high purity. However, the band appeared around 70 kDa(Figure 3), which differs from the expected molecular weight of nsp5 (33.8 kDa). Purification details can be seen in Engineering Success
Reference:
1. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9. PMID: 32272481.
2. Zhao Y, Zhu Y, Liu X, Jin Z, Duan Y, Zhang Q, Wu C, Feng L, Du X, Zhao J, Shao M, Zhang B, Yang X, Wu L, Ji X, Guddat LW, Yang K, Rao Z, Yang H. Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2. Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117142119. doi: 10.1073/pnas.2117142119. Epub 2022 Apr 5. PMID: 35380892; PMCID: PMC9172370.
3.Wu Y, Ma L, Zhuang Z, Cai S, Zhao Z, Zhou L, Zhang J, Wang PH, Zhao J, Cui J. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal Transduct Target Ther. 2020 Oct 6;5(1):221. doi: 10.1038/s41392-020-00332-2. PMID: 33024073; PMCID: PMC7537955.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 390